XOMA Royalty (XOMA) Preferred Shares (2010 - 2026)

XOMA Royalty (XOMA) reported Preferred Shares of $49000.0 for Q1 2026, little changed on a YoY basis from $49000.0 in Q1 2025, and little changed sequentially from $49000.0 in Q4 2025.

XOMA Royalty (XOMA) Preferred Shares (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 8 years of Preferred Shares data on file, last reported at $49000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Preferred Shares changed 0.0% year-over-year to $49000.0; the trailing twelve-month figure through Mar 2026 stood at $49000.0 (changed 0.0% YoY), and the FY2025 full-year result was $49000.0, changed 0.0% from the prior year.
  • Preferred Shares steadied at $49000.0 in Q1 2026, from $49000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $49000.0 in Q1 2022 to a low of $49000.0 in Q1 2022.
  • A 5-year average of $49000.0 and a median of $49000.0 in 2022 frame the typical range for Preferred Shares.
  • Peak annual rise in Preferred Shares reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • Tracing XOMA's Preferred Shares over 5 years: stood at $49000.0 in 2022, then changed by 0.0% to $49000.0 in 2023, then changed by 0.0% to $49000.0 in 2024, then changed by 0.0% to $49000.0 in 2025, then changed by 0.0% to $49000.0 in 2026.
  • Business Quant data shows XOMA's Preferred Shares at $49000.0 in Q1 2026, $49000.0 in Q4 2025, and $49000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - 49,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 49,000.00
Dec 31, 2025 49,000.00
Jun 30, 2025 49,000.00
Mar 31, 2025 49,000.00
Dec 31, 2024 49,000.00
Sep 30, 2024 49,000.00
Jun 30, 2024 49,000.00
Mar 31, 2024 49,000.00
Dec 31, 2023 49,000.00
Sep 30, 2023 49,000.00
Jun 30, 2023 49,000.00
Mar 31, 2023 49,000.00
Dec 31, 2022 49,000.00
Sep 30, 2022 49,000.00
Jun 30, 2022 49,000.00
Mar 31, 2022 49,000.00
Dec 31, 2021 49,000.00
Sep 30, 2021 49,000.00
Jun 30, 2021 49,000.00
Mar 31, 2021 49,000.00